Eddie Gibson

Eddie Gibson has a diverse work experience in various roles and industries. Eddie started their career in 1997 as a Manager at ZS associates. Eddie then moved on to Bristol-Myers Squibb, where they held several roles, including European Brand Lead and Country Manager for various regions. In 2012, they joined AVEO Oncology as a Senior Director, responsible for global commercialization and market access initiatives. Eddie has also served as a Non-Executive Director for ProteinLogic Ltd, Wickenstones Ltd, Poolbeg Pharma plc, and NANOVERY. Currently, they are the Chairman and Non-Executive Director at O-INNOVATIONS. Additionally, Eddie has been recognized as a Global Pharma Key Opinion Leader at the Korean Health Industry Development Institute.

Eddie Gibson's education history begins with their attendance at Biddulph high school, although the dates are not provided. After completing high school, they went on to attend the University of Bristol from 1991 to 1994, where they earned a Bachelor of Science (B.Sc) degree in Chemistry. Following this, Eddie enrolled at the University of Oxford from 1994 to 1997, and successfully obtained a Doctor of Philosophy (D.Phil) degree in Biochemistry. In 2008 to 2009, they pursued further education at INSEAD, completing the CEDEP program, although no specific field of study is mentioned.